Shilpa Medicare Ltd

Shilpa Medicare Limited together with its subsidiaries engages in the manufacturing and selling active pharmaceutical ingredients (APIs) intermediates and formulations in India the United States Europe and internationally. It's primary oncology and non-oncology APIs include capecitabine gemcitabine hydrochloride axitinib erlotinib hydrochloride and irinotecan hydrochloride as well as ambroxol tranexmic acid and ursodeoxycholic acid; and new drug delivery systems peptides/biotech products specialty chemicals etc. The company also provides contract manufacturing of various dosage forms such as tablets capsules liquid injections lyophilized injectables and sterile dry powder injectables. It is also involved in the wind power generation activities. Shilpa Medicare Limited was incorporated in 1987 and is headquartered in Raichur India.